Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-3633

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-3633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3633 3)

Pdp (68071 3633 3)
This is information related to Lansoprazole 15mg capsules distributed by NuCare Pharmaceuticals, Inc. The product contains specific details such as lot numbers, NDC codes, expiration dates, and warnings about keeping it out of reach of children. It also includes instructions to call a doctor for medical advice about side effects and provides the FDA reporting hotline. The storage temperature recommendation is between 68-77°F.*
FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-01 (F53ca2be A290 4157 Ad95 D24dfe3344f9 01)

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)
This is a table presenting the Mean Severity of Day Heartburn by Study Day for evaluable patients. The severity levels are categorized as Severe, Moderate, Mild, and None. The data shows the severity levels over different study days for patients taking Placebo, Lansoprazole 15 mg, and Lansoprazole 30 mg. It provides insights into the effectiveness of the treatments in reducing heartburn symptoms over time.*
FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)
This text provides data on the mean severity of night heartburn by study day for evaluable patients. The severity is rated on a scale of 0 to 3, with 3 being severe, 2 moderate, 1 mild, and 0 none. The evaluation includes three groups: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The mean severity of night heartburn is tracked over the course of days from the start of treatment.*
FDA Label Image

Pdp (F53ca2be A290 4157 Ad95 D24dfe3344f9 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.